JP2024532836A5 - - Google Patents
Info
- Publication number
- JP2024532836A5 JP2024532836A5 JP2024509425A JP2024509425A JP2024532836A5 JP 2024532836 A5 JP2024532836 A5 JP 2024532836A5 JP 2024509425 A JP2024509425 A JP 2024509425A JP 2024509425 A JP2024509425 A JP 2024509425A JP 2024532836 A5 JP2024532836 A5 JP 2024532836A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110961038 | 2021-08-20 | ||
| CN202110961038.5 | 2021-08-20 | ||
| PCT/CN2022/113882 WO2023020625A1 (zh) | 2021-08-20 | 2022-08-22 | 包含抗TIGIT抗体和TGF-βR的融合蛋白、其药物组合物及用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532836A JP2024532836A (ja) | 2024-09-10 |
| JPWO2023020625A5 JPWO2023020625A5 (https=) | 2024-11-12 |
| JP2024532836A5 true JP2024532836A5 (https=) | 2024-11-12 |
Family
ID=85239528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509425A Pending JP2024532836A (ja) | 2021-08-20 | 2022-08-22 | 抗ＴＩＧＩＴ抗体及びＴＧＦ－βＲを含む融合タンパク質、並びにその医薬組成物及び使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250319169A2 (https=) |
| EP (1) | EP4389771A4 (https=) |
| JP (1) | JP2024532836A (https=) |
| KR (1) | KR20240046905A (https=) |
| CN (1) | CN116003625A (https=) |
| AU (1) | AU2022330896A1 (https=) |
| CA (1) | CA3229166A1 (https=) |
| IL (1) | IL310541A (https=) |
| MX (1) | MX2024002147A (https=) |
| WO (1) | WO2023020625A1 (https=) |
| ZA (1) | ZA202401813B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021372706A1 (en) * | 2020-10-26 | 2023-06-08 | Akeso Biopharma, Inc. | Anti-tigit antibody, and pharmaceutical composition and use thereof |
| JP2026508210A (ja) * | 2023-02-20 | 2026-03-10 | 中山康方生物医▲藥▼有限公司 | ＴＧＦ－βＲＩＩ細胞外領域断片を含む融合タンパク質、その医薬組成物、およびその使用 |
| CN119613559B (zh) * | 2023-09-14 | 2026-01-02 | 中山康方生物医药有限公司 | 药物组合及用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JO3096B1 (ar) * | 2008-11-07 | 2017-03-15 | Imclone Llc | الأجسام المضادة لمستقبل ii مضاد tgfb |
| CN107207594B (zh) * | 2014-12-23 | 2019-05-07 | 百时美施贵宝公司 | 针对tigit的抗体 |
| EP3349792A1 (en) * | 2015-09-14 | 2018-07-25 | Compass Therapeutics LLC | Compositions and methods for treating cancer via antagonism of the cd155/tigit pathway and tgf- |
| CA2994858C (en) * | 2015-09-25 | 2024-01-23 | Genentech, Inc. | Anti-tigit antibodies and methods of use |
| JP7068169B2 (ja) * | 2016-01-08 | 2022-05-16 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 条件付活性ヘテロ二量体ポリペプチド及びその使用方法 |
| WO2017152088A1 (en) * | 2016-03-04 | 2017-09-08 | JN Biosciences, LLC | Antibodies to tigit |
| AU2018264455B2 (en) * | 2017-05-12 | 2024-12-12 | Jiangsu Hengrui Medicine Co., Ltd. | Fusion protein containing TGF-beta receptor and medicinal uses thereof |
| US11512129B2 (en) * | 2017-09-29 | 2022-11-29 | Jiangsu Hengrui Medicine Co., Ltd. | TIGIT antibody, antigen-binding fragment thereof, and medical use thereof |
| JP7348899B2 (ja) * | 2017-12-08 | 2023-09-21 | マレンゴ・セラピューティクス，インコーポレーテッド | 多重特異性分子及びその使用 |
| KR20200109313A (ko) * | 2018-01-15 | 2020-09-22 | 난징 레전드 바이오테크 씨오., 엘티디. | Tigit에 대한 항체 및 이의 변이체 |
| CN114555099A (zh) * | 2019-06-23 | 2022-05-27 | 广东天科雅生物医药科技有限公司 | 抗alpp car-t细胞疗法 |
| EP4054633A1 (en) * | 2019-11-05 | 2022-09-14 | Merck Patent GmbH | Combined inhibition of pd-1, tgfb and tigit for the treatment of cancer |
| WO2021093760A1 (zh) * | 2019-11-12 | 2021-05-20 | 江苏恒瑞医药股份有限公司 | 含有TGF-β受体的融合蛋白及其医药用途 |
| US20220409684A1 (en) * | 2019-11-18 | 2022-12-29 | The Brigham And Women's Hospital, Inc. | Codon optimized new generation regulatable fusogenic oncolytic herpes simplex virus type 1 virus and methods of use |
| AU2021372706A1 (en) * | 2020-10-26 | 2023-06-08 | Akeso Biopharma, Inc. | Anti-tigit antibody, and pharmaceutical composition and use thereof |
| CN114106182B (zh) * | 2022-01-26 | 2022-05-17 | 中山康方生物医药有限公司 | 抗tigit的抗体及其用途 |
| CN114181310B (zh) * | 2022-02-14 | 2022-07-05 | 中山康方生物医药有限公司 | 抗tigit抗体、其药物组合物及用途 |
-
2022
- 2022-08-22 AU AU2022330896A patent/AU2022330896A1/en active Pending
- 2022-08-22 WO PCT/CN2022/113882 patent/WO2023020625A1/zh not_active Ceased
- 2022-08-22 CA CA3229166A patent/CA3229166A1/en active Pending
- 2022-08-22 IL IL310541A patent/IL310541A/en unknown
- 2022-08-22 EP EP22857934.8A patent/EP4389771A4/en active Pending
- 2022-08-22 KR KR1020247008893A patent/KR20240046905A/ko active Pending
- 2022-08-22 CN CN202211006660.1A patent/CN116003625A/zh active Pending
- 2022-08-22 US US18/684,899 patent/US20250319169A2/en active Pending
- 2022-08-22 MX MX2024002147A patent/MX2024002147A/es unknown
- 2022-08-22 JP JP2024509425A patent/JP2024532836A/ja active Pending
-
2024
- 2024-03-01 ZA ZA2024/01813A patent/ZA202401813B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532836A5 (https=) | ||
| CL2025003693A1 (es) | Barra colectora conductora rectangular tubular con núcleo macizo y disipación de calor interna | |
| BR102022025291A2 (https=) | ||
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR102022023461A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BR202022001779U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| CN307045962S (https=) | ||
| BY13170U (https=) | ||
| CN307045221S (https=) | ||
| CN307044327S (https=) | ||
| CN307044189S (https=) | ||
| CN307045460S (https=) | ||
| BY23963C1 (https=) |